This study compares two treatments for Stage I Non-Small Cell Lung Cancer (NSCLC): surgery and stereotactic body radiation therapy (SBRT). SBRT is a type of radiation treatment that targets tumors with high accuracy. To join, you must have Stage I NSCLC, which means the cancer is in its early stages. A CT or PET/CT scan is needed to check your lung cancer stage.
Eligible participants must be at least 18 and able to undergo either surgery or SBRT, based on doctors’ decisions. You should not have had previous lung cancer treatments or other cancers that might affect the study. You'll need to understand and agree to the study terms.
- Duration: The study lasts for 3 years, collecting patient-reported outcomes.
- Eligibility: Must be able to have either surgery or SBRT, with no previous overlapping treatments.
- Risks: Discuss potential risks with your doctor to understand which treatment is best for you.
Talk to your doctor if you are considering joining this study to learn more about how it might help you and what it involves.